FAAH and breast carcinoma: In contrast, the degradation of lipids by fatty acid amide hydrolase (FAAH) prevents tumor progression and lung metastasis both in vitro and in vivo, and FAAH serves as a biomarker for longer survival in breast cancer patients [30].